Efficacy and safety of anti-CD45-saporin as conditioning agent for RAG deficiency

J Allergy Clin Immunol. 2021 Jan;147(1):309-320.e6. doi: 10.1016/j.jaci.2020.04.033. Epub 2020 May 6.

Abstract

Background: Mutations in the recombinase-activating genes cause severe immunodeficiency, with a spectrum of phenotypes ranging from severe combined immunodeficiency to immune dysregulation. Hematopoietic stem cell transplantation is the only curative option, but a high risk of graft failure and poor immune reconstitution have been observed in the absence of myeloablation.

Objectives: Our aim was to improve multilineage engraftment; we tested nongenotoxic conditioning with anti-CD45 mAbs conjugated with saporin CD45 (CD45-SAP).

Methods: Rag1-KO and Rag1-F971L mice, which represent models of severe combined immune deficiency and combined immune deficiency with immune dysregulation, respectively, were conditioned with CD45-SAP, CD45-SAP plus 2 Gy of total body irradiation (TBI), 2 Gy of TBI, 8 Gy of TBI, or no conditioning and treated by using transplantation with lineage-negative bone marrow cells from wild-type mice. Flow cytometry and immunohistochemistry were used to assess engraftment and immune reconstitution. Antibody responses to 2,4,6-trinitrophenyl-conjugated keyhole limpet hemocyanin were measured by ELISA, and presence of autoantibody was detected by microarray.

Results: Conditioning with CD45-SAP enabled high levels of multilineage engraftment in both Rag1 mutant models, allowed overcoming of B- and T-cell differentiation blocks and thymic epithelial cell defects, and induced robust cellular and humoral immunity in the periphery.

Conclusions: Conditioning with CD45-SAP allows multilineage engraftment and robust immune reconstitution in mice with either null or hypomorphic Rag mutations while preserving thymic epithelial cell homeostasis.

Keywords: RAG deficiency; anti-CD45–saporin; conditioning; engraftment; hematopoietic stem cell transplantation; immune reconstitution; immunotoxin; thymic epithelial cells.

Publication types

  • Research Support, N.I.H., Intramural
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Allografts
  • Animals
  • Antibodies, Monoclonal / adverse effects
  • Antibodies, Monoclonal / pharmacology*
  • Bone Marrow Transplantation*
  • Homeodomain Proteins / genetics*
  • Homeodomain Proteins / immunology
  • Immunoconjugates / adverse effects
  • Immunoconjugates / pharmacology*
  • Leukocyte Common Antigens / antagonists & inhibitors*
  • Leukocyte Common Antigens / genetics
  • Leukocyte Common Antigens / immunology
  • Mice
  • Mice, Knockout
  • Saporins / adverse effects
  • Saporins / pharmacology*
  • Severe Combined Immunodeficiency / genetics
  • Severe Combined Immunodeficiency / immunology
  • Severe Combined Immunodeficiency / therapy*
  • Transplantation Conditioning*

Substances

  • Antibodies, Monoclonal
  • Homeodomain Proteins
  • Immunoconjugates
  • RAG-1 protein
  • Leukocyte Common Antigens
  • Ptprc protein, mouse
  • Saporins